Association between statin therapy as primary prevention and mortality in adults 50 years and older with chronic kidney disease without other indications.
Abstract
Statin therapy was associated with lower all-cause mortality but was underutilized in adults ≥50 years with CKD. These findings have supported broader implementation of guideline-recommended statin therapy.
What are the key findings of this study?
Statin therapy helps older adults with chronic kidney disease live longer. This treatment is not being used enough, even though it has been shown to reduce deaths. Making sure more people can get statins could save lives. It's important for healthcare providers to follow guidelines and recommend these drugs more often. 🩺
Key Points
Objective
This research aims to evaluate the impact of statin therapy on mortality rates in adults aged 50 and older with chronic kidney disease.
Methods
- Analyzed the association between statin therapy and all-cause mortality.
- Population included adults aged 50 years and older with chronic kidney disease.
- Investigated the utilization patterns of statin therapy in the target population.
Results
- Statin therapy was associated with lower all-cause mortality rates.
- Underutilization of statin therapy was observed despite its benefits.
What is the clinical evidence from this study?
Study Design
Other
Key Finding
Statin therapy was associated with lower all-cause mortality in adults aged ≥50 with chronic kidney disease, yet remains underutilized.